Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609

Watchlist Manager
Shanghai HeartCare Medical Technology Corp Ltd Logo
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Watchlist
Price: 26.45 HKD -6.54%
Market Cap: 1B HKD

Intrinsic Value

6609 price has not been updated for more than 1 year. This may indicate that the stock has been delisted.

The intrinsic value of one Shanghai HeartCare Medical Technology Corp Ltd stock under the Base Case scenario is 26.11 HKD. Compared to the current market price of 26.45 HKD, Shanghai HeartCare Medical Technology Corp Ltd is Overvalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
26.11 HKD
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Shanghai HeartCare Medical Technology Corp Ltd

Shanghai HeartCare Medical Technology Corp Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Shanghai HeartCare Medical Technology Corp Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
CN
Health Care
Market Cap
1B HKD
IPO
Aug 20, 2021
CN
Health Care
Market Cap
1B HKD
IPO
Aug 20, 2021
Price
HK$false
EPS
ÂĄfalse
Shanghai HeartCare Medical Technology Corp Ltd
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Shanghai HeartCare Medical Technology Corp Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Shanghai HeartCare Medical Technology Corp Ltd
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Shanghai HeartCare Medical Technology Corp Ltd

Balance Sheet Decomposition
Shanghai HeartCare Medical Technology Corp Ltd

Current Assets 1B
Cash & Short-Term Investments 713.7m
Receivables 94.7m
Other Current Assets 215.4m
Non-Current Assets 182.5m
Long-Term Investments 9.5m
PP&E 117.8m
Intangibles 43.3m
Other Non-Current Assets 11.9m
Efficiency

Free Cash Flow Analysis
Shanghai HeartCare Medical Technology Corp Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Shanghai HeartCare Medical Technology Corp Ltd

Revenue
277.9m CNY
Cost of Revenue
-96.2m CNY
Gross Profit
181.7m CNY
Operating Expenses
-196.3m CNY
Operating Income
-14.6m CNY
Other Expenses
988k CNY
Net Income
-13.6m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shanghai HeartCare Medical Technology Corp Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROIC is Increasing
ROE is Increasing
37/100
Profitability
Score

Shanghai HeartCare Medical Technology Corp Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shanghai HeartCare Medical Technology Corp Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Shanghai HeartCare Medical Technology Corp Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shanghai HeartCare Medical Technology Corp Ltd

Wall Street analysts forecast Shanghai HeartCare Medical Technology Corp Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai HeartCare Medical Technology Corp Ltd is 20.4 HKD with a low forecast of 20.2 HKD and a high forecast of 21 HKD.

Lowest
Price Target
20.2 HKD
24% Downside
Average
Price Target
20.4 HKD
23% Downside
Highest
Price Target
21 HKD
21% Downside
View Analyst Estimates
View Analyst Estimates

Dividends

Shanghai HeartCare Medical Technology Corp Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Shanghai HeartCare Medical Technology Corp Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Shanghai HeartCare Medical Technology Corp Ltd stock?

The intrinsic value of one Shanghai HeartCare Medical Technology Corp Ltd stock under the Base Case scenario is 26.11 HKD.

Is Shanghai HeartCare Medical Technology Corp Ltd stock undervalued or overvalued?

Compared to the current market price of 26.45 HKD, Shanghai HeartCare Medical Technology Corp Ltd is Overvalued by 1%.

Back to Top